A transdiagnostic network analysis of psychosocial-clinical-cognitive functioning in young people with bipolar and major depressive disorders - Scorecard - MDSpire

A transdiagnostic network analysis of psychosocial-clinical-cognitive functioning in young people with bipolar and major depressive disorders

  • By

  • Longbin Du

  • Xiaofen Zong

  • Jinxin He

  • Mengyao Feng

  • Hongjie Li

  • Yupan Tan

  • Li Dong

  • Xia Sun

  • Yuanyuan Zhang

  • Shuxian Yin

  • Huan Peng

  • Jie Yao

  • Qi Wen

  • Maolin Hu

  • March 17, 2026

  • 0 min

Share

Clinical Scorecard: A Network Analysis Examining Psychosocial, Clinical, and Cognitive Functioning in Youth with Bipolar and Major Depressive Disorders

At a Glance

CategoryDetail
ConditionBipolar Disorder (BD) and Major Depressive Disorder (MDD)
Key MechanismsInterrelated clinical symptoms, psychosocial factors, and cognitive dysfunction forming a transdiagnostic network with central and bridge nodes
Target PopulationYouth aged 10-24 years with BD or MDD
Care SettingClinical and research settings focusing on early mood disorder intervention

Key Highlights

  • Identified two transdiagnostic clusters: symptom-psychosocial and neurocognition.
  • Depression and anhedonia are central in symptom-psychosocial cluster; processing speed and attention central in neurocognition cluster.
  • Attention and self-harm act as bridge nodes linking symptom-psychosocial and cognitive clusters.

Guideline-Based Recommendations

Diagnosis

  • Adopt a transdiagnostic, dimensional approach rather than rigid categorical diagnosis for BD and MDD in youth.
  • Use cognitive stratification to identify patient subgroups with distinct cognitive profiles.

Management

  • Target central symptoms such as depression and anhedonia and bridge nodes like attention and self-harm in interventions.
  • Incorporate cognitive-informed strategies addressing processing speed and attention deficits.

Monitoring & Follow-up

  • Regularly assess clinical symptoms, cognitive function, and psychosocial factors to capture dynamic interactions.
  • Monitor cognitive subgroups for changes in nodal and global network strength.

Risks

  • Recognize the risk of diagnostic conversion and comorbidity between BD and MDD.
  • Be vigilant for self-harm behaviors as a key bridge factor influencing symptom and cognitive domains.

Patient & Prescribing Data

Youth aged 10-24 with BD-I, BD-II, or MDD

Interventions should be personalized based on cognitive subgroup stratification and focus on central and bridge nodes to optimize outcomes.

Clinical Best Practices

  • Employ network analysis-informed assessments to identify key symptom and cognitive targets.
  • Integrate psychosocial support addressing interpersonal relationships and social functioning.
  • Use dimensional and cognitive-informed frameworks to guide diagnosis and treatment planning.
  • Consider early intervention during adolescence and young adulthood to mitigate progression.

References

Original Source(s)

Related Content